The risk of developing dementia may be double what was previously thought. But there are things the U.S. can do to help fight ...

Recent headlines suggest that up to 42% of people ages 55 and older face an eventual dementia diagnosis. But some experts have a follow-up message: Risk isn't the same as destiny, and there are ways ...

Researchers at the University of Kentucky's Sanders-Brown Center on Aging are at the forefront of advancing dementia research ...

Kyung Bo Kim discovered compounds that improved cognitive function regardless of amyloid plaque buildup — an encouraging sign ...

The FDA has accepted the BLA for lecanemab-irmb SC for weekly maintenance dosing in the treatment of early Alzheimer disease.

Regular aerobic exercise could significantly reduce disease markers associated with Alzheimer's, new research has found. The findings provide new hope in the battle against this devastating disorder.

Research spanning more than 20 years has led the UPV/EHU's Neurochemistry and Neurodegeneration group under Dr. Rafael Rodríguez-Puertas to discover a promising avenue for the development of new ...

Alzheimer's disease is the most common type of dementia. Here, we break down what to know about this disease, including: What ...

The finding has implications for all of us, write Harvard physician-researchers Christopher Worsham and Anupam Jena.

The Phase Ia trial is designed to assess the safety and efficacy of the company’s drug designed to target chemicals thought to be a cause of Alzheimer’s disease.